脂酶C-β3对于血管收缩是不可或缺的,但对于血管增大是不可或缺的
Seo Yeon Jin1, Jung Min Ha1, Hye Jin Kum1
1Medical Research Institute, Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Republic of Korea.
Experimental & molecular medicine
|June 30, 2024
概括
脂酶C-β3 (PLC-β3) 对于通过NOX1-介导的活性氧物种 (ROS) 进行血管光滑肌肉细胞增殖至关重要,但对于血压调节或血管收缩至关重要.
科学领域:
- 血管生物学 血管生物学
- 细胞信号传递 细胞信号传递
- 高血压研究 高血压研究
背景情况:
- ангиотензин II (AngII) 刺激血管光滑肌细胞 (VSMC) 的收缩和增殖.
- AngII激活脂酶C-β (PLC-β),导致的调动和反应性氧物种 (ROS) 的产生.
- 控制VSMC收缩与扩散的独特信号通路仍然不完全理解.
研究的目的:
- 阐明控制AngII诱导的VSMC收缩和扩散的特定分子机制.
- 研究PLC-β3和NADPH氧化酶 (NOX) 在这些过程中的作用.
主要方法:
- 药物抑制和基因沉默的PLC-β3和NOX异型 (NOX1,NOX4).
- 评估VSMC的收缩,扩散,迁移和ROS生产.
- 在基因改造小鼠 (PLC-β3∆SMC,NOX1-/-,NOX4-/-) 中对中腔动脉收缩,高血压发育和新内膜形成的分析.
主要成果:
- PLC-β3和NOX1,但不是NOX4,对于AngII诱导的VSMC扩散,迁移和ROS产生至关重要.
- 抑制或抑制PLC-β3或NOX并没有影响AngII诱导的VSMC收缩或中枢动脉收缩.
- 在NOX1-/-和PLC-β3∆SMC小鼠中观察到AngII诱导的高血压,而neointima形成被抑制.
结论:
- PLC-β3对于AngII介导的血管增生至关重要,通过NOX1依赖的ROS生成运作.
- 对于AngII诱导的血管收缩和血压调节,PLC-β3是不可缺少的.
- 这些发现区分了血管增殖与收缩的信号通路.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
IP3/DAG Signaling Pathway
12.0K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K
Nitric Oxide Signaling Pathway
5.0K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.0K
Vascular Spasm
1.4K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.4K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K


